表紙
市場調査レポート

アブレーション技術の世界市場:製品 (高周波、超音波、不可逆的エレクトロポレーション、凍結療法、マイクロ波) ・用途別 (心臓血管、癌、疼痛処理、美容整形、眼科、婦人科) の予測 〜2020年

Ablation Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) & Application (Cardiovascular, Cancer, Pain Management, Cosmetic Surgery, Ophthalmology, Gynecology) - Global Forecasts to 2020

発行 MarketsandMarkets 商品コード 247577
出版日 ページ情報 英文 169 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.02円で換算しております。
Back to Top
アブレーション技術の世界市場:製品 (高周波、超音波、不可逆的エレクトロポレーション、凍結療法、マイクロ波) ・用途別 (心臓血管、癌、疼痛処理、美容整形、眼科、婦人科) の予測 〜2020年 Ablation Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) & Application (Cardiovascular, Cancer, Pain Management, Cosmetic Surgery, Ophthalmology, Gynecology) - Global Forecasts to 2020
出版日: 2016年02月08日 ページ情報: 英文 169 Pages
概要

世界のアブレーション技術市場は、2015年以降CAGR (複合年間成長率) 10.5%の伸びで、2020年には44億4,000万米ドルの規模に達する見込みとなっています。2015年には、米国、ドイツ、フランスおよび英国などの成熟市場が大きなシェアを占めていましたが、今後5年間においてはアジア太平洋地域のCAGRが最も高くなるものと見られています。癌罹患率の上昇、心臓血管疾患有病率の拡大、次世代アブレーション製品および技術の登場、低侵襲処置の導入拡大、病院、外科手術およびアブレーションセンター数の増加、ならびに医療コスト補償シナリオの改善などが、市場の発展を促進する主な要因です。

当レポートでは、世界のアブレーション技術市場を取り上げ、市場の概要、市場発展促進・阻害要因、市場における課題および機会を概括し、タイプ別・製品別・用途別・地域別に市場の現状と見通しについて調査分析するとともに、競合環境、主要企業のプロファイルをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 プレミアムインサイト

第5章 市場概要

  • イントロダクション
  • 市場区分
  • 市場動態
    • 市場発展促進要因
      • アブレーション処置数の増加
      • 癌罹患率の上昇
      • 心臓血管疾患有病率の拡大
      • 次世代アブレーション製品および技術の登場
      • 低侵襲処置の導入拡大
      • 病院、外科手術およびアブレーションセンター数の増加
      • 確立された市場における補償シナリオの改善
    • 市場発展阻害要因
      • 発展途上国における機器の再利用および再加工
      • 医療コスト抑制施策
    • 課題
      • 厳しい規制ガイドライン
      • 治療における課題
    • 市場機会
      • 新たなアブレーション機器の開発に向けた資金の増加
      • 新興市場
      • トレーニングプログラム数の増加
    • 動向
      • 市場の再編
      • 発展途上国にますます重点を置く国際企業

第6章 世界のアブレーション技術市場、タイプ別

  • イントロダクション
  • 高周波アブレーション
  • レーザー/光アブレーション
  • 超音波アブレーション
  • 電気的アブレーション
  • 冷凍アブレーション
  • マイクロアブレーション
  • 波不可逆的エレクトロポレーション
  • 熱水アブレーション

第7章 世界のアブレーション技術市場、製品別

  • イントロダクション
  • 高周波アブレーター
  • レーザー/光アブレーター
  • 超音波アブレーター
  • 電気的アブレーター
  • 冷凍アブレーター
  • マイクロアブレーター
  • 波不可逆的エレクトロポレーション
  • 熱水アブレーター

第8章 世界のアブレーション技術市場、用途別

  • イントロダクション
  • 心臓血管疾患治療
  • 癌治療
    • 肝臓癌
    • 腎臓癌
    • 前立腺癌
    • 肺癌
    • 骨転移
    • 乳癌
  • 眼科治療
  • 疼痛処理
  • 婦人科治療
  • 泌尿器治療
  • 整形外科治療
  • 美容整形/美顔整形手術
  • その他治療

第9章 世界のアブレーション技術市場、地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • その他欧州
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • その他アジア太平洋
  • その他地域

第10章 競合環境

  • 概要
  • 市場シェア分析
    • アブレーション技術市場における主要企業
  • 競合状況・動向
    • 新製品発表・認可
    • 合併・買収
    • 地域拡大
    • 合意、合弁事業
    • その他の動向

第11章 企業プロファイル (業績、製品・サービス、主要戦略、最近の動き)

  • イントロダクション
  • MEDTRONIC PLC
  • BIOSENSE WEBSTER, INC. (JOHNSON & JOHNSON INC.の子会社)
  • ST. JUDE MEDICAL, INC.
  • BOSTON SCIENTIFIC CORPORATION
  • ANGIODYNAMICS, INC.
  • ATRICURE, INC.
  • CONMED CORPORATION
  • OLYMPUS CORPORATION
  • SMITH & NEPHEW
  • GALIL MEDICAL INC.

第12章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MD 2738

The global ablation technologies market is estimated to grow at a CAGR of 10.5% from 2015 to 2020 and will be valued at USD 4.44 billion. Although mature markets (such as the U.S., Germany, France, and the U.K.) held larger shares in the ablation technologies market in 2015, the Asia-Pacific region is poised to grow at the highest CAGR in the next five years. Factors such as growing popularity of minimally invasive surgeries, government efforts to increase population access for elective surgeries, rising focus of global players, large population base and improving healthcare infrastructure and the rising focus of international and domestic players on the Asia-Pacific ablation technologies market are propelling its growth.

The growth of the ablation technologies market is driven by factors such as increasing number of ablation procedures, rising incidence of cancer, growing prevalence of cardiovascular diseases, emergence of next-generation ablation products and technologies, growing adoption of minimally-invasive procedures, increasing number of hospitals, surgical, and ablation centers and improving reimbursement scenario in established markets. However, factors such as reuse and reprocessing of devices in developing countries, Healthcare cost-containment measures, and ongoing healthcare reforms in the U.S. are restraining the growth of the market. Increasing funding for the development of novel ablation devices, emerging markets such as China, India, and Mexico are creating opportunities for the players involved in the ablation technologies market.

In this report, the global ablation technologies market has been segmented on the basis of type of product (light/laser ablators, radiofrequency ablators, electrical ablators, ultrasound ablators, microwave ablators, cryoablation devices, and hydrothermal ablators), type of technology (light/laser, radiofrequency, electrical, ultrasound, microwave, cryoblation, and hydrothermal technologies), and type of application (cancer, cardiovascular, gynecological, ophthalmological, urological, orthopedic, pain management and cosmetic surgery). The radiofrequency ablators market is estimated to account for the largest share of the global ablation technologies market in 2015, followed by the light/laser ablators market. Use of RF ablators in primary interventional therapy for the treatment of many cardiac arrhythmias is a key factor driving the segment. Better temperature control by RF ablators as compared to other ablation products (such as electrical and microwave ablators), clinical advantages offered by temperature-controlled RF ablators over traditional ablation approaches are further supporting the growth of the segment.

The microwave ablators segment is estimated to grow at the highest CAGR from 2015 to 2020. This high growth is primarily due to its high success rate in cancer treatment as well as advantages offered by microwave ablation over RF ablation (for example, microwave ablation devices can produce larger ablation zones and do not suffer as much from the heat sink effect that can handicap RF ablation).

Geographically, North America (comprising the U.S. and Canada) commands the largest share of the global ablation technologies market in 2015, followed by Europe. The ablation technologies market in North America is primarily driven by various factors including presence of a large number of ablation product manufacturers, significant rate of adoption of ablation treatment, large patient population base, growing demand for minimally invasive surgical procedures and continuously rising prevalence of chronic disorders such as cancer and heart diseases (especially atrial fibrillation).

The global ablation technologies market is highly competitive, with a large number of global and local players. As of 2014, the global ablation technologies market was dominated by Medtronic, Inc. (Ireland), Biosense Webster, Inc. (U.S.), St. Jude Medical, Inc. (U.S.), and Boston Scientific Corporation (U.S.), which together accounted for ~50% of the market. New product launches, pipeline product enhancements, and partnerships, agreements, and joint ventures are the major strategies adopted by most of the market players to achieve growth in the ablation technologies market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis -industry analysis (industry trends, PEST analysis, and Porter's five force model), market share analysis of top ten players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the ablation technologies market, high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on ablation devices offered by the top 10 players in the ablation technologies market. The report analyzes the ablation technologies market by type of product, technology, and application across geographies
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the ablation technologies market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various ablation devices across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the ablation technologies market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the ablation technologies market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
  • 1.4. MARKETS COVERED
    • 1.4.1. YEARS CONSIDERED FOR THE STUDY
  • 1.5. CURRENCY
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
      • 2.2.1.1. Key data from secondary sources
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Key data from primary sources
    • 2.2.3. MARKET SIZE ESTIMATION METHODOLOGY
    • 2.2.4. RESEARCH METHODOLOGY: TOP-DOWN APPROACH
    • 2.2.5. RESEARCH METHODOLOGY: BOTTOM-UP APPROACH
  • 2.3. RESEARCH DESIGN
  • 2.4. MARKET DATA VALIDATION AND TRIANGULATION
    • 2.4.1. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CURRENT MARKET SCENARIO
  • 3.3. FUTURE OUTLOOK
  • 3.4. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL ABLATION TECHNOLOGIES MARKET OVERVIEW (2015-2020)
  • 4.2. GEOGRAPHICAL SNAPSHOT OF THE GLOBAL ABLATION TECHNOLOGIES MARKET
  • 4.3. GLOBAL ABLATION TECHNOLOGIES MARKET, BY TYPE AND REGION (2015)
  • 4.4. GLOBAL ABLATION TECHNOLOGIES MARKET, BY APPLICATION AND REGION (2015 VS. 2020)
  • 4.5. GLOBAL ABLATION TECHNOLOGIES MARKET SIZE, BY PRODUCT (2015 VS. 2020)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Increasing number of ablation procedures
      • 5.3.1.2. Rising incidence of cancer
      • 5.3.1.3. Growing prevalence of cardiovascular diseases
      • 5.3.1.4. Emergence of next-generation ablation products and technologies
      • 5.3.1.5. Growing adoption of minimally invasive procedures
      • 5.3.1.6. Increasing number of hospitals, surgical, and ablation centers
      • 5.3.1.7. Improving reimbursement scenario in established markets
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. Reuse and reprocessing of devices in developing countries
      • 5.3.2.2. Healthcare cost-containment measures
    • 5.3.3. CHALLENGES
      • 5.3.3.1. Stringent regulatory guidelines
      • 5.3.3.2. Therapeutic challenges
    • 5.3.4. OPPORTUNITIES
      • 5.3.4.1. Increasing funding for the development of novel ablation devices
      • 5.3.4.2. Emerging markets
      • 5.3.4.3. Rising number of training programs
    • 5.3.5. TRENDS
      • 5.3.5.1. Market consolidation
      • 5.3.5.2. Increasing focus of global players towards developing nations

6. GLOBAL ABLATION TECHNOLOGIES MARKET, BY TYPE 49

  • 6.1. INTRODUCTION
  • 6.2. RADIOFREQUENCY ABLATION
  • 6.3. LASER/LIGHT ABLATION
  • 6.4. ULTRASOUND ABLATION
  • 6.5. ELECTRICAL ABLATION
  • 6.6. CRYOABLATION
  • 6.7. MICROWAVE ABLATION
  • 6.8. HYDROTHERMAL ABLATION

7. GLOBAL ABLATION TECHNOLOGIES MARKET, BY PRODUCT

  • 7.1. INTRODUCTION
  • 7.2. RADIOFREQUENCY ABLATORS
    • 7.2.1. TEMPERATURE-CONTROLLED RADIOFREQUENCY ABLATORS
    • 7.2.2. FLUID-COOLED RADIOFREQUENCY ABLATORS
    • 7.2.3. ROBOTIC CATHETER MANIPULATION SYSTEMS
  • 7.3. LASER/LIGHT ABLATORS
    • 7.3.1. EXCIMER LASER ABLATORS
    • 7.3.2. COLD LASER ABLATORS
  • 7.4. ULTRASOUND ABLATORS
    • 7.4.1. ULTRASONIC SURGICAL ABLATION SYSTEMS
    • 7.4.2. HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) ABLATORS
    • 7.4.3. EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY (ESWL) SYSTEMS
    • 7.4.4. MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND (MRGFUS) ABLATORS
  • 7.5. ELECTRICAL ABLATORS
    • 7.5.1. ARGON PLASMA/BEAM COAGULATORS
    • 7.5.2. IRREVERSIBLE ELECTROPORATION ABLATORS
  • 7.6. CRYOABLATION DEVICES
    • 7.6.1. TISSUE CONTACT PROBES
    • 7.6.2. TISSUE SPRAY PROBES
    • 7.6.3. EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES
  • 7.7. MICROWAVE ABLATORS
    • 7.7.1. MICROWAVE THERMOTHERAPY DEVICES
  • 7.8. HYDROTHERMAL ABLATORS
    • 7.8.1. ENDOMETRIAL HYDROTHERMAL BALLOON ABLATION DEVICES

8. GLOBAL ABLATION TECHNOLOGIES MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. CARDIOVASCULAR DISEASE TREATMENT
  • 8.3. CANCER TREATMENT
    • 8.3.1. LIVER CANCER
    • 8.3.2. KIDNEY CANCER
    • 8.3.3. PROSTATE CANCER
    • 8.3.4. LUNG CANCER
    • 8.3.5. BONE METASTASIS
    • 8.3.6. BREAST CANCER
  • 8.4. OPHTHALMOLOGIC TREATMENT
  • 8.5. PAIN MANAGEMENT
  • 8.6. GYNECOLOGICAL TREATMENT
  • 8.7. UROLOGICAL TREATMENT
  • 8.8. ORTHOPEDIC TREATMENT
  • 8.9. COSMETIC/ AESTHETIC SURGERY
  • 8.10. OTHER TREATMENTS

9. GLOBAL ABLATION TECHNOLOGIES MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
    • 9.2.2. CANADA
  • 9.3. EUROPE
    • 9.3.1. GERMANY
    • 9.3.2. FRANCE
    • 9.3.3. U.K.
    • 9.3.4. REST OF EUROPE
  • 9.4. ASIA-PACIFIC
    • 9.4.1. JAPAN
    • 9.4.2. CHINA
    • 9.4.3. INDIA
    • 9.4.4. REST OF ASIA-PACIFIC
  • 9.5. REST OF THE WORLD

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS
    • 10.2.1. KEY PLAYERS IN THE ABLATION TECHNOLOGIES MARKET
  • 10.3. COMPETITIVE SITUATION AND TRENDS
    • 10.3.1. NEW PRODUCT LAUNCHES & APPROVALS
    • 10.3.2. MERGERS & ACQUISITIONS
    • 10.3.3. GEOGRAPHICAL EXPANSIONS
    • 10.3.4. AGREEMENTS AND JOINT VENTURES
    • 10.3.5. OTHER DEVELOPMENTS

11. COMPANY PROFILES*

  • 11.1. INTRODUCTION
  • 11.2. MEDTRONIC PLC
  • 11.3. BIOSENSE WEBSTER, INC. (A SUBSIDIARY OF JOHNSON & JOHNSON INC.)
  • 11.4. ST. JUDE MEDICAL, INC.
  • 11.5. BOSTON SCIENTIFIC CORPORATION
  • 11.6. ANGIODYNAMICS, INC.
  • 11.7. ATRICURE, INC.
  • 11.8. CONMED CORPORATION
  • 11.9. OLYMPUS CORPORATION
  • 11.10. SMITH & NEPHEW
  • 11.11. GALIL MEDICAL INC.

*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.4. AVAILABLE CUSTOMIZATIONS
  • 12.5. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: GLOBAL ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 2: ABLATION TECHNOLOGIES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 3: RADIOFREQUENCY ABLATION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 4: LASER/LIGHT ABLATION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 5: ULTRASOUND ABLATION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 6: ELECTRICAL ABLATION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 7: CRYOABLATION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 8: MICROWAVE ABLATION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 9: HYDROTHERMAL ABLATION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 10: GLOBAL ABLATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 11: RADIOFREQUENCY ABLATORS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 12: RADIOFREQUENCY ABLATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 13: TEMPERATURE-CONTROLLED RADIOFREQUENCY ABLATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 14: FLUID-COOLED RADIOFREQUENCY ABLATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 15: ROBOTIC CATHETER MANIPULATION SYSTEMS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 16: LASER/LIGHT ABLATORS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 17: LASER/LIGHT ABLATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 18: EXCIMER LASER ABLATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 19: COLD LASER ABLATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 20: ULTRASOUND ABLATORS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 21: ULTRASOUND ABLATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 22: ULTRASONIC SURGICAL ABLATION SYSTEMS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 23: HIGH-INTENSITY FOCUSED ULTRASOUND ABLATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 24: EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY SYSTEMS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 25: MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND ABLATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 26: ELECTRICAL ABLATORS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 27: ELECTRICAL ABLATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 28: ARGON PLASMA/BEAM COAGULATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 29: IRREVERSIBLE ELECTROPORATION ABLATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 30: CRYOABLATION DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 31: CRYOABLATION DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 32: TISSUE CONTACT PROBES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 33: TISSUE SPRAY PROBES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 34: EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 35: MICROWAVE ABLATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 36: HYDROTHERMAL ABLATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 37: GLOBAL ABLATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 38: ABLATION TECHNOLOGIES MARKET SIZE FOR CARDIOVASCULAR DISEASE TREATMENT, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 39: ABLATION TECHNOLOGIES MARKET SIZE FOR CANCER TREATMENT, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 40: ABLATION TECHNOLOGIES MARKET SIZE FOR OPHTHALMOLOGIC TREATMENT, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 41: ABLATION TECHNOLOGIES MARKET SIZE FOR PAIN MANAGEMENT, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 42: ABLATION TECHNOLOGIES MARKET SIZE FOR GYNECOLOGICAL TREATMENT, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 43: ABLATION TECHNOLOGIES MARKET SIZE FOR UROLOGIC TREATMENT, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 44: ABLATION TECHNOLOGIES MARKET SIZE FOR ORTHOPEDIC TREATMENT, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 45: ABLATION TECHNOLOGIES MARKET SIZE FOR COSMETIC/ AESTHETIC SURGERY, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 46: ABLATION TECHNOLOGIES MARKET SIZE FOR OTHER TREATMENTS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 47: GLOBAL ABLATION TECHNOLOGIES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 48: NORTH AMERICA: ABLATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 49: NORTH AMERICA: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 50: NORTH AMERICA: ABLATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 51: U.S.: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 52: CANADA: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 53: EUROPE: ABLATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 54: EUROPE: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 55: EUROPE: ABLATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 56: GERMANY: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 57: FRANCE: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 58: U.K.: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 59: REST OF EUROPE: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 60: ASIA-PACIFIC: ABLATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 61: ASIA-PACIFIC: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 62: ASIA-PACIFIC: ABLATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 20130U2020 (USD MILLION)
  • TABLE 63: JAPAN: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 64: CHINA: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 65: INDIA: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 66: APAC: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 67: ROW: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 68: ROW: ABLATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 69: TOP 5 NEW PRODUCT LAUNCHES & APPROVALS, 2012-2015
  • TABLE 70: MERGERS & ACQUISITIONS, 2012-2015
  • TABLE 71: GEOGRAPHICAL EXPANSIONS, 2012-2015
  • TABLE 72: TOP 3 AGREEMENTS AND JOINT VENTURES, 2012-2015
  • TABLE 73: TOP 5 OTHER DEVELOPMENTS, 2012-2015

LIST OF FIGURES

  • FIGURE 1: GLOBAL ABLATION TECHNOLOGIES MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: DATA TRIANGULATION METHODOLOGY
  • FIGURE 4: GLOBAL ABLATION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 5: ABLATION TECHNOLOGIES MARKET SIZE, BY TYPE (2015 VS. 2020)
  • FIGURE 6: ABLATION TECHNOLOGIES MARKET SHARE, BY PRODUCT (2015 VS. 2020)
  • FIGURE 7: ABLATION TECHNOLOGIES MARKET SIZE, BY APPLICATION (2015 VS. 2020)
  • FIGURE 8: ABLATION TECHNOLOGIES MARKET SHARE, BY REGION (2015)
  • FIGURE 9: RISING INCIDENCES OF CANCER & CARDIAC DISEASES-PRIMARY DRIVER OF THE ABLATION TECHNOLOGIES MARKET
  • FIGURE 10: INDIA AND CHINA ARE THE MOST LUCRATIVE MARKETS FOR ABLATION PRODUCT MANUFACTURERS
  • FIGURE 11: U.S. TO COMMAND THE LARGEST SHARE OF THE ABLATION TECHNOLOGIES MARKET IN 2015
  • FIGURE 12: CARDIOVASCULAR DISEASE TREATMENT SEGMENT TO DOMINATE THE ABLATION TECHNOLOGIES MARKET IN 2020
  • FIGURE 13: RADIOFREQUENCY ABLATORS WILL CONTINUE TO DOMINATE THE MARKET TILL 2020
  • FIGURE 14: ABLATION TECHNOLOGIES MARKET SEGMENTATION
  • FIGURE 15: GLOBAL ABLATION TECHNOLOGIES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 16: GLOBAL PREVALENCE OF CANCER: EXPECTED TREND TILL 2020
  • FIGURE 17: INCREASING NUMBER OF ABLATION PROCEDURES PROPELLING THE MARKET GROWTH
  • FIGURE 18: COST-CONTAINMENT MEASURES BY GOVERNMENTS ARE RESTRAINING THE MARKET GROWTH FOR ABLATION DEVICES
  • FIGURE 19: STRINGENT REGULATORY GUIDELINES RESTRAIN THE GROWTH OF THE ABLATION TECHNOLOGIES MARKET
  • FIGURE 20: DEVELOPING COUNTRIES PAVE NEWER GROWTH AVENUES FOR MARKET PLAYERS
  • FIGURE 21: MICROWAVE ABLATION IS THE FASTEST-GROWING SEGMENT OF THE GLOBAL ABLATION TECHNOLOGIES MARKET
  • FIGURE 22: MICROWAVE ABLATION IS THE FASTEST-GROWING SEGMENT IN THE GLOBAL ABLATION TECHNOLOGIES MARKET
  • FIGURE 23: CARDIOVASCULAR DISEASE TREATMENT ABLATION MARKET TO GROW AT THE HIGHEST CAGR IN THE FORECAST PERIOD
  • FIGURE 24: GLOBAL ABLATION TECHNOLOGIES MARKET SHARE, BY COUNTRY (2015-2020)
  • FIGURE 25: NORTH AMERICA: ABLATION TECHNOLOGIES MARKET SNAPSHOT
  • FIGURE 26: EUROPE: ABLATION TECHNOLOGIES MARKET SNAPSHOT
  • FIGURE 27: ASIA-PACIFIC: ABLATION TECHNOLOGIES MARKET SNAPSHOT
  • FIGURE 28: LEADING MARKET PLAYERS ADOPTED NEW PRODUCT LAUNCHES & APPROVALS AS THEIR KEY GROWTH STRATEGY FROM 2012 TO 2015
  • FIGURE 29: GLOBAL ABLATION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 30: NEW PRODUCT LAUNCHES & APPROVALS WAS THE KEY STRATEGY
  • FIGURE 31: GEOGRAPHIC REVENUE MIX OF TOP MARKET PLAYERS
  • FIGURE 32: MEDTRONIC PLC: COMPANY SNAPSHOT
  • FIGURE 33: JOHNSON AND JOHNSON: COMPANY SNAPSHOT
  • FIGURE 34: ST. JUDE MEDICAL, INC.: COMPANY SNAPSHOT
  • FIGURE 35: BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • FIGURE 36: ANGIODYNAMICS, INC.: COMPANY SNAPSHOT
  • FIGURE 37: ATRICURE, INC.: COMPANY SNAPSHOT
  • FIGURE 38: CONMED CORPORATION: COMPANY SNAPSHOT
  • FIGURE 39: OLYMPUS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 40: SMITH & NEPHEW: COMPANY SNAPSHOT
Back to Top